Improving adherence to antipsychotic pharmacotherapy

PS Masand, M Narasimhan - Current clinical pharmacology, 2006 - ingentaconnect.com
Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …
被引用次数：120 相关文章

Improving adherence to antipsychotic pharmacotherapy.

PS Masand, M Narasimhan - Current Clinical Pharmacology, 2006 - europepmc.org
OBJECTIVE: To review the consequences of nonadherence to antipsychotic
pharmacotherapy in patients with schizophrenia, as well as associated risk factors for …

Improving adherence to antipsychotic pharmacotherapy

PS Masand, M Narasimhan - Current clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Objective To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …
[PDF] researchgate.net

[PDF][PDF] Improving Adherence to Antipsychotic Pharmacotherapy

PS Masand, M Narasimhan - Current Clinical Pharmacology, 2006 - researchgate.net
Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …
[PDF] academia.edu

[PDF][PDF] Improving Adherence to Antipsychotic Pharmacotherapy

PS Masand, M Narasimhan - Current Clinical Pharmacology, 2006 - academia.edu
Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …
[PDF] researchgate.net

[PDF][PDF] Improving Adherence to Antipsychotic Pharmacotherapy

PS Masand, M Narasimhan - Current Clinical Pharmacology, 2006 - researchgate.net
Objective: To review the consequences of nonadherence to antipsychotic pharmacotherapy
in patients with schizophrenia, as well as associated risk factors for nonadherence and …